It was another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought you the latest and most interesting news as it happened. In association with BARIAlink, here are the Top 10 most read articles on Bariatric News in April 2024.
Latest findings from the IFSO Global Registry
Registries offer opportunities to make meaningful comparisons between countries on the demographics, characteristics, operation types and approaches, and trends in metabolic and bariatric surgery (MBS) procedure types, according to the latest paper from the IFSO Global Registry Collaboration. The data presented in the latest paper, represents the key findings of the eighth report of the IFSO Global Registry, which includes data from 24 national and two regional registries, totalling 502,150 procedures...(more)
No significant differences between LigaSure and Harmonic in LSG outcomes
There are no significant differences between LigaSure (Medtronic) and Harmonic (Ethicon Endo-Surgery) devices in terms of operative time, length of hospital stay, rates of intraoperative complications or post-operative complications and re-operation rates among patients undergoing laparoscopic sleeve gastrectomy (LSG), according to a systematic review and meta-analysis by researchers from Kuwait, Jordan and Bahrain...(more)
Endoscopic sleeve gastroplasty more cost-effective than with semaglutide
An economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is cost saving compared with semaglutide and the price threshold analyses revealed that a three-fold decrease in the price of semaglutide is needed to achieve non-dominance. The findings are primarily due to the increased effectiveness and lower costs of ESG and the increased dropout rates over time with semaglutide, according to US researchers....(more)
Banded-RYGB outcomes show maintenance of weight loss out to ten years
The addition of a silicone ring to a Roux-en-Y gastric bypass (banded- RYGB) results in the maintenance of weight loss ten years post-operative, according to a study by researchers from the Zuyderland Medical Center (ZMC) in The Netherlands. In addition to decreased weight loss occurrence, the procedure also reduced the number of associated medical problems and lowered the number of patients with long-term complications...(more)
Endoscopic BariTon™ implant intended to mimic sleeve gastrectomy and bypass surgery
In February 2024, BariaTek Medical announced that it had successfully performed the first-in-human implant of the BariTon™, an endoscopically delivered implant that consists of a gastric and an intestinal part, thereby both reducing food intake and calorie absorption - mimicking the mechanisms of sleeve gastrectomy and gastric bypass surgery. Bariatric News talked to Youssef Biadillah, Chief Executive Officer at BariaTek, about the limitations of current surgical and endoscopic options to treat obesity, the potential of the device...(more)
Looking forward to IFSO 2024
This year’s 27th IFSO World Congress returns to Australia for the first time since the 11th World Congress in Sydney in 2006. We caught up with Dr Ahmad Aly, co-organising President of the Congress to preview some of the key sessions, what’s new at this year’s meeting and what the beautiful city of Melbourne and Australia, has to offer visiting delegates...(more)
The evolution of the UK’s National Bariatric Surgery Registry
In October 2023, Mr Omar Khan was appointed as the Chair of the British Obesity & Metabolic Surgery Society’s (BOMSS) National Bariatric Surgery Registry Committee. In this interview, we discuss the evolution of the NBSR, some of the changes he would like to see and the challenges in collecting and reporting patient data...(more)
BEATLES: Bariatric embolization using BTG-001933 microspheres is feasible
Bariatric embolization of arteries (BAE) using novel customized tightly calibrated 100-200µm radiopaque embolic microspheres “BTG-001933” (Boston Scientific) is feasible and appears to be well tolerated by patients with severe obesity, according to researchers led by a team from Johns Hopkins University, Baltimore, MD. The researchers noted that weight loss outcomes demonstrated higher efficacy, compared to other embolic agents used in previous studies...(more)
The status of bariatric surgery in Egypt
With approximately 100 million inhabitants, Egypt is the 14th-most populated country in the world, and the third-most populated in Africa. Bariatric News spoke with Professor Mohamed Hany from Alexandria University and Madina Women’s Hospital, Alexandria, Egypt, about the increasing rates of obesity and the status of bariatric surgery in the country...(more)
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure
Chinese and Singaporean researchers have discovered that apolipoprotein A-IV (apoA-IV) was significantly increased in diabetic patients living with obesity after laparoscopic sleeve gastrectomy (LSG), and similar changes were observed in patients after Roux-en-Y gastric bypass (RYGB). Furthermore, apoA-IV and its derivative peptide, T55−121, improved energy expenditure and glucose tolerance in diabetic mice...(more)
Click on the image below to register for 68th BARIAlink Academy: SADI-S
